Sign In

Login

Password

Forgot Password ? Sign Up

리스페리돈 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "리스페리돈" in Korean language version.

refsWebsite
Global rank Korean rank
16nih.gov
4th place
4th place
13doi.org
2nd place
3rd place
4web.archive.org
1st place
1st place
2mfds.go.kr
low place
1,240th place
2fda.gov
447th place
433rd place
1who.int
195th place
98th place
1drugs.com
399th place
141st place
1whanin.com
low place
5,004th place
1myunginph.co.kr
low place
1,987th place

doi.org

dx.doi.org

  • Komossa K, Rummel-Kluge C, Schwarz S, Schmid F, Hunger H, Kissling W, Leucht S (2011년 1월 19일). “Risperidone versus other atypical antipsychotics for schizophrenia.”. 《The Cochrane database of systematic reviews》 (1): CD006626. doi:10.1002/14651858.CD006626.pub2. PMID 21249678. 
  • Hasnain M, Vieweg WV, Hollett B (July 2012). “Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians”. 《Postgraduate Medicine》 124 (4): 154–67. doi:10.3810/pgm.2012.07.2577. PMID 22913904. 
  • Leucht S, Cipriani A, Spineli L; 외. (September 2013). “Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis”. 《Lancet》 382 (9896): 951–62. doi:10.1016/S0140-6736(13)60733-3. PMID 23810019. 
  • Osser DN, Roudsari MJ, Manschreck T (2013). “The psychopharmacology algorithm project at the Harvard South Shore Program: an update on schizophrenia”. 《Harv Rev Psychiatry》 21 (1): 18–40. doi:10.1097/HRP.0b013e31827fd915. PMID 23656760. 
  • Glick ID, Correll CU, Altamura AC; 외. (December 2011). “Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach”. 《J Clin Psychiatry》 72 (12): 1616–27. doi:10.4088/JCP.11r06927. PMID 22244023. 
  • Leucht C, Heres S, Kane JM, Kissling W, Davis JM, Leucht S (April 2011). “Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials”. 《Schizophr. Res.》 127 (1-3): 83–92. doi:10.1016/j.schres.2010.11.020. PMID 21257294. 
  • Lafeuille MH, Dean J, Carter V; 외. (August 2014). “Systematic review of long-acting injectables versus oral atypical antipsychotics on hospitalization in schizophrenia”. 《Curr Med Res Opin》 30 (8): 1643–55. doi:10.1185/03007995.2014.915211. PMID 24730586. 
  • Nielsen J, Jensen SO, Friis RB, Valentin JB, Correll CU (September 2014). “Comparative Effectiveness of Risperidone Long-Acting Injectable vs First-Generation Antipsychotic Long-Acting Injectables in Schizophrenia: Results From a Nationwide, Retrospective Inception Cohort Study”. 《Schizophr Bull》. doi:10.1093/schbul/sbu128. PMID 25180312. 
  • Muralidharan K, Ali M, Silveira LE; 외. (September 2013). “Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: a meta-analysis of placebo-controlled trials”. 《J Affect Disord》 150 (2): 408–14. doi:10.1016/j.jad.2013.04.032. PMID 23735211. 
  • Nivoli AM, Murru A, Goikolea JM; 외. (October 2012). “New treatment guidelines for acute bipolar mania: a critical review”. 《J Affect Disord》 140 (2): 125–41. doi:10.1016/j.jad.2011.10.015. PMID 22100133. 
  • Yildiz A, Vieta E, Leucht S, Baldessarini RJ (January 2011). “Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials”. 《Neuropsychopharmacology》 36 (2): 375–89. doi:10.1038/npp.2010.192. PMC 3055677. PMID 20980991. 
  • Peruzzolo TL, Tramontina S, Rohde LA, Zeni CP (2013). “Pharmacotherapy of bipolar disorder in children and adolescents: an update”. 《Rev Bras Psiquiatr》 35 (4): 393–405. doi:10.1590/1516-4446-2012-0999. PMID 24402215. 
  • Gitlin M, Frye MA (May 2012). “Maintenance therapies in bipolar disorders”. 《Bipolar Disord》. 14 Suppl 2: 51–65. doi:10.1111/j.1399-5618.2012.00992.x. PMID 22510036. 

drugs.com

  • “Respiridone”. 《The American Society of Health-System Pharmacists》. 2011년 4월 3일에 확인함. 

fda.gov

accessdata.fda.gov

mfds.go.kr

drug.mfds.go.kr

myunginph.co.kr

nih.gov

ncbi.nlm.nih.gov

  • Komossa K, Rummel-Kluge C, Schwarz S, Schmid F, Hunger H, Kissling W, Leucht S (2011년 1월 19일). “Risperidone versus other atypical antipsychotics for schizophrenia.”. 《The Cochrane database of systematic reviews》 (1): CD006626. doi:10.1002/14651858.CD006626.pub2. PMID 21249678. 
  • Hasnain M, Vieweg WV, Hollett B (July 2012). “Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians”. 《Postgraduate Medicine》 124 (4): 154–67. doi:10.3810/pgm.2012.07.2577. PMID 22913904. 
  • “Risperidone — PubMed Health”. Ncbi.nlm.nih.gov. 2012년 9월 3일에 원본 문서에서 보존된 문서. 2012년 3월 23일에 확인함. 
  • Leucht S, Cipriani A, Spineli L; 외. (September 2013). “Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis”. 《Lancet》 382 (9896): 951–62. doi:10.1016/S0140-6736(13)60733-3. PMID 23810019. 
  • Osser DN, Roudsari MJ, Manschreck T (2013). “The psychopharmacology algorithm project at the Harvard South Shore Program: an update on schizophrenia”. 《Harv Rev Psychiatry》 21 (1): 18–40. doi:10.1097/HRP.0b013e31827fd915. PMID 23656760. 
  • Barry SJ, Gaughan TM, Hunter R (2012). “Schizophrenia”. 《Clin Evid (Online)》 2012. PMC 3385413. PMID 23870705. 
  • Glick ID, Correll CU, Altamura AC; 외. (December 2011). “Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach”. 《J Clin Psychiatry》 72 (12): 1616–27. doi:10.4088/JCP.11r06927. PMID 22244023. 
  • Leucht C, Heres S, Kane JM, Kissling W, Davis JM, Leucht S (April 2011). “Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials”. 《Schizophr. Res.》 127 (1-3): 83–92. doi:10.1016/j.schres.2010.11.020. PMID 21257294. 
  • Lafeuille MH, Dean J, Carter V; 외. (August 2014). “Systematic review of long-acting injectables versus oral atypical antipsychotics on hospitalization in schizophrenia”. 《Curr Med Res Opin》 30 (8): 1643–55. doi:10.1185/03007995.2014.915211. PMID 24730586. 
  • Nielsen J, Jensen SO, Friis RB, Valentin JB, Correll CU (September 2014). “Comparative Effectiveness of Risperidone Long-Acting Injectable vs First-Generation Antipsychotic Long-Acting Injectables in Schizophrenia: Results From a Nationwide, Retrospective Inception Cohort Study”. 《Schizophr Bull》. doi:10.1093/schbul/sbu128. PMID 25180312. 
  • Muralidharan K, Ali M, Silveira LE; 외. (September 2013). “Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: a meta-analysis of placebo-controlled trials”. 《J Affect Disord》 150 (2): 408–14. doi:10.1016/j.jad.2013.04.032. PMID 23735211. 
  • Nivoli AM, Murru A, Goikolea JM; 외. (October 2012). “New treatment guidelines for acute bipolar mania: a critical review”. 《J Affect Disord》 140 (2): 125–41. doi:10.1016/j.jad.2011.10.015. PMID 22100133. 
  • Yildiz A, Vieta E, Leucht S, Baldessarini RJ (January 2011). “Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials”. 《Neuropsychopharmacology》 36 (2): 375–89. doi:10.1038/npp.2010.192. PMC 3055677. PMID 20980991. 
  • Peruzzolo TL, Tramontina S, Rohde LA, Zeni CP (2013). “Pharmacotherapy of bipolar disorder in children and adolescents: an update”. 《Rev Bras Psiquiatr》 35 (4): 393–405. doi:10.1590/1516-4446-2012-0999. PMID 24402215. 
  • Gitlin M, Frye MA (May 2012). “Maintenance therapies in bipolar disorders”. 《Bipolar Disord》. 14 Suppl 2: 51–65. doi:10.1111/j.1399-5618.2012.00992.x. PMID 22510036. 
  • Maher AR, Theodore G (June 2012). “Summary of the comparative effectiveness review on off-label use of atypical antipsychotics”. 《J Manag Care Pharm》 18 (5 Suppl B): S1–20. PMID 22784311. 

web.archive.org

whanin.com

who.int

apps.who.int